Results 281 to 290 of about 849,024 (375)

Determination of the Viremia and Genotype Distribution of the Hepatitis C Virus and the Seroprevalence of HIV Co-Infection. [PDF]

Infect Dis Clin Microbiol
Akıllı FM, Turan-Gökçe D, Akıllı B.   +2 more
europepmc   +1 more source

Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus [PDF]

, 1994
Irving, W L, James, V, Neal, K R, Simmonds, P N, Underwood, J C E   +4 more
core   +1 more source

Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization.

, 1993
K T Nouri Aria, Richard Sallie, D. V. Sangar, Graeme Alexander, Heather M. Smith, J C Byrne, Bernard Portmann, A L Eddleston, Roger Williams   +8 more
openalex   +1 more source

Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses. [PDF]

, 1991
L Berk, Solko W. Schalm, R. A. Heijtink
openalex   +1 more source

Electrochemical sensing strategies for on‐site testing of pathogenic nucleic acids

Electrochemical Science Advances, EarlyView.
Abstract Rapid and reliable on‐site pathogen testing is crucial for diagnosing and managing human health. Nucleic acids (NAs) containing genetic information are valuable target molecules for pathogen testing, and sensitive and rapid detection of NAs using electrochemical approaches has been intensively investigated.
Yusuke Kanno, Shuzo Masui, Yusuke Ota, Ryoichi Saito, Takasi Nisisako   +4 more
wiley   +1 more source

IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia [PDF]

, 1993
A L'Abbate, Sebastiano Cutrupi, M ROGNETTA, Carmelo Fabiano, Antonio Craxı̀   +4 more
openalex   +1 more source

Exploring the Potential and Advancements of Circular RNA Therapeutics

Exploration, EarlyView.
Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang, Lianqing Wang, Chunbo Dong, Jialong Liu, Guoxin Cui, Shan Gao, Zhida Liu   +6 more
wiley   +1 more source

Autoimmune manifestations and direct-acting antiviral drugs in Egyptian patients with hepatitis C virus infection: A cohort study. [PDF]

J Int Med Res
Elmakhzangy HI, Rabie MA, Bahgat DM, Attia DH, Elsayed AE, Mohammed RHA.   +5 more
europepmc   +1 more source

Hepatitis C virus infection from blood and blood products [PDF]

, 1994
C.L. van der Poel
openalex   +1 more source

Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol

Exploration, EarlyView.
Using celastrol as a case study, this review summarizes various target discovery strategies for natural products, including chemical proteomics, protein microarray, degradation‐based protein profiling, proteome‐wide label‐free approaches, network pharmacology, target‐based drug screening, and indirect strategies.
Yanbei Tu, Guiyu Dai, Yanyan Chen, Lihua Tan, Hanqing Liu, Meiwan Chen   +5 more
wiley   +1 more source